Concentrix (CNXC) News Today

Mawer Investment Management Ltd. boosted its position in shares of Concentrix Co. (NASDAQ:CNXC - Free Report) by 40.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 169,766 shares of the company's stock a

Principal Financial Group Inc. lessened its position in Concentrix Co. (NASDAQ:CNXC - Free Report) by 54.4% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 156,043 shares of the company's stock after selling 186,390 shares during the p

Pzena Investment Management LLC grew its position in Concentrix Co. (NASDAQ:CNXC - Free Report) by 46.6% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,484,907 shares of the company's stock after purchasing an additional 471,699 sha

Bank of New York Mellon Corp grew its position in Concentrix Co. (NASDAQ:CNXC - Free Report) by 14.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 532,771 shares of the company's s

Concentrix Co. (NASDAQ:CNXC - Get Free Report) EVP Cormac J. Twomey sold 400 shares of Concentrix stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $74.63, for a total transaction of $29,852.00. Following the sale, the executive vice president now owns 29,327 shares of the company's stock, valued at $2,188,674.01. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Allspring Global Investments Holdings LLC lessened its holdings in Concentrix Co. (NASDAQ:CNXC - Free Report) by 25.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 215,145 shares of the company's stock after selling 74,396 s

Bank of America upgraded Concentrix from an "underperform" rating to a "neutral" rating and lifted their price objective for the company from $65.00 to $85.00 in a research note on Wednesday.

SG Americas Securities LLC acquired a new stake in Concentrix Co. (NASDAQ:CNXC - Free Report) during the second quarter, according to its most recent filing with the SEC. The firm acquired 22,830 shares of the company's stock, valued at approximately $1,445,000. Other hedge funds and other institut

DekaBank Deutsche Girozentrale reduced its position in shares of Concentrix Co. (NASDAQ:CNXC - Free Report) by 98.1% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 943 shares of the company's stock a

Boston Partners boosted its position in shares of Concentrix Co. (NASDAQ:CNXC - Free Report) by 4.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 365,515 shares of the company's stock after acquiring an addi

Lazard Asset Management LLC cut its holdings in Concentrix Co. (NASDAQ:CNXC - Free Report) by 90.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,613 shares of the company's stock af

Silvercrest Asset Management Group LLC lessened its stake in shares of Concentrix Co. (NASDAQ:CNXC - Free Report) by 69.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 182,500 shares of the company's stock after s

Bayesian Capital Management LP purchased a new stake in Concentrix Co. (NASDAQ:CNXC - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 9,936 shares of the company's stock, valued at approximately $658,000. Several other hedge funds have

Vanguard Group Inc. cut its stake in shares of Concentrix Co. (NASDAQ:CNXC - Free Report) by 0.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 5,317,547 shares of the company's stock after selling 46,346 shares

Natixis bought a new stake in Concentrix Co. (NASDAQ:CNXC - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 8,186 shares of the company's stock, valued at approximately $542,000. Other institution

Russell Investments Group Ltd. lowered its stake in shares of Concentrix Co. (NASDAQ:CNXC - Free Report) by 14.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 87,251 shares

Concentrix Co. (NASDAQ:CNXC - Get Free Report) has earned a consensus recommendation of "Hold" from the five ratings firms that are currently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and thr

Quantbot Technologies LP purchased a new position in Concentrix Co. (NASDAQ:CNXC - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 22,482 shares of the company's stock, valued at approximately

Tweedy Browne Co LLC boosted its stake in shares of Concentrix Co. (NASDAQ:CNXC - Free Report) by 21.6% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 173,338 shares of the company's stock after acquiring an additional 30,798 shares during the period. Con

Retirement Systems of Alabama reduced its position in shares of Concentrix Co. (NASDAQ:CNXC - Free Report) by 55.2% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 59,044 shares of the company's stock after selling 72,824

Concentrix Co. (NASDAQ:CNXC - Get Free Report) was the recipient of a large decrease in short interest in the month of June. As of June 15th, there was short interest totalling 2,770,000 shares, a decrease of 5.1% from the May 31st total of 2,920,000 shares. Currently, 5.9% of the shares of the company are sold short. Based on an average daily volume of 515,200 shares, the days-to-cover ratio is currently 5.4 days.

Concentrix Co. (NASDAQ:CNXC - Get Free Report) EVP Cormac J. Twomey sold 400 shares of the stock in a transaction dated Friday, June 28th. The shares were sold at an average price of $63.21, for a total transaction of $25,284.00. Following the completion of the sale, the executive vice president now owns 30,127 shares of the company's stock, valued at approximately $1,904,327.67. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

Concentrix Co. (NASDAQ:CNXC) declared a quarterly dividend on Wednesday, June 26th. Stockholders of record on Friday, July 26th will be given a dividend of 0.303 per share on Tuesday, August 6th. This represents a $1.21 dividend on an annualized basis and a dividend yield of 1.93%. The ex-dividend date of this dividend is Friday, July 26th.

Goldman Sachs Group Inc. cut its stake in shares of Concentrix Co. (NASDAQ:CNXC - Free Report) by 27.5% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 168,808 shares of the company's stock after selling 63,874 shares during the period. Goldman Sachs Grou

Shares of Concentrix Co. (NASDAQ:CNXC - Get Free Report) have received an average recommendation of "Hold" from the five brokerages that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold re

Concentrix (NASDAQ:CNXC) Shares Gap Up to $58.02

Canaccord Genuity Group reaffirmed a "buy" rating and set a $125.00 price target on shares of Concentrix in a research note on Thursday.

Concentrix (NASDAQ:CNXC) updated its third quarter 2024 earnings guidance. The company provided EPS guidance of 2.760-3.040 for the period, compared to the consensus estimate of 3.220. The company also issued revenue guidance of $2.4 billionillion-$2.4 billionillion, compared to the consensus estimate of $2.4 billionillion.

Vanguard Group Inc. boosted its holdings in shares of Concentrix Co. (NASDAQ:CNXC - Free Report) by 23.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 5,363,893 shares of the company's stock after purchasing an additional 1,

Barrington Research reissued an "outperform" rating and set a $84.00 target price on shares of Concentrix in a research note on Friday.

Concentrix (NASDAQ:CNXC) will be releasing earnings after the market closes on Wednesday, June 26, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=603843)

Concentrix Co. (NASDAQ:CNXC - Get Free Report) saw a large growth in short interest in May. As of May 31st, there was short interest totalling 2,920,000 shares, a growth of 14.1% from the May 15th total of 2,560,000 shares. Based on an average daily volume of 527,300 shares, the days-to-cover ratio is presently 5.5 days. Currently, 6.2% of the shares of the company are short sold.

FIL Ltd reduced its position in Concentrix Co. (NASDAQ:CNXC - Free Report) by 2.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,657,443 shares of the company's stock after selling 39,875 shares during

Groupe Bruxelles Lambert bought a new stake in Concentrix Co. (NASDAQ:CNXC - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 8,773,667 shares of the company's stock, valued at approximately $861,662,000. Concentrix accounts for about

Hotchkis & Wiley Capital Management LLC reduced its stake in shares of Concentrix Co. (NASDAQ:CNXC - Free Report) by 10.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 127,015 shares of the company's stock after selling 15,270 shares d

Allianz Asset Management GmbH lessened its stake in Concentrix Co. (NASDAQ:CNXC - Free Report) by 66.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 14,971 shares of the company's stock after selling 29,646 shares duri